Bio-printing in the context of end-to-end scalable tissue-engineered ATMP manufacturing
Year: 2024
Type: article
Abstract: 3D bio-printing technologies have been constantly evolving over the past 15 years in order to address health challenges, such as the need for regeneration or replacement of human organs and tissues. To date, there are no bio-printed tissue engineered products in the EU market and no active clinical trials...
Source: Cell and Gene Therapy Insights
Authors: Isaak Decoene, Ioannis Papantoniou
Institution: KU Leuven
Language: English
Subfield: Biomedical Engineering
Field: Engineering
Domain: Physical Sciences
Open Access status: hybrid
OpenAlex ID: W7115589552
FWCI:
Cites:
Cited by:
Related to: